Betaxolol Recalled Due to Packaging Mix-Up

One lot of Betaxolol was recalled due to the discovery of a rogue oxycodone tablet in a bottle.

Screen Shot 2022 04 18 At 2 42 14 Pm
Getty Images

A recent Forbes article discussed a situation where an oxycodone tablet made its way into a bottle of blood pressure medication, spurring a recall. KVK Tech issued the recall of a specific lot of their betaxolol tablets due to the discovery of a single 5 mg oxycodone HCl tablet. The mix-up could have potential serious consequences, as these medications are obviously not interchangeable. Betaxolol is a beta blocker that lowers blood pressure by dilating blood vessels and slowing heart rate, while oxycodone is a controlled substance typically prescribed for pain relief, but it can also cause sedation, euphoria, and respiratory depression. 

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026